Visions for a JACIE Quality Management System 4.0 - Takeaways - MDSpire

Visions for a JACIE Quality Management System 4.0

  • By

  • John A. Snowden

  • Eoin McGrath

  • Kim Orchard

  • Nicolaus Kröger

  • Anna Sureda

  • Alois Gratwohl

  • September 29, 2021

  • 0 min

Share

  • 1

    Hematopoietic stem cell transplantation (HSCT) evolved from early experiments demonstrating the potential to repopulate hematopoiesis in rodents.

  • 2

    Quality management systems (QMS) were informally present in early HSCT, emphasizing responsibility, transparency, and continuous improvement despite initial failures.

  • 3

    The pandemic prompted a retrospective evaluation of HSCT evolution and quality management, aligning with the concept of 'Medicine 4.0' and digital transformation.

  • 4

    The introduction of standardized reporting in the 1980s established foundational principles for data collection and outcome analysis in HSCT.

  • 5

    The 1990s saw the implementation of mandatory reporting and audits, enhancing trust and accuracy in HSCT outcomes through systematic quality control.

Original Source(s)

Visions for a JACIE Quality Management System 4.0

  • by John A. Snowden, Eoin McGrath, Kim Orchard, Nicolaus Kröger, Anna Sureda, Alois Gratwohl

  • September 29, 2021

Related Content

Molecular Pathology Insights into Hematologic Malignancies: An In-Depth Analysis of Genetic and Chromosomal Abnormalities and Their Clinical Implications

Fertility preservation and subsequent reproductive outcomes in female pediatric patients with hematologic malignancies

Research Leaders Across New York State Form Empire State Cellular Therapy Consortium

To expand on early progress in the emerging field of cell and gene therapy, five research centers across New York State are collaborating to develop new cell therapies for cancer and other diseases.

  • by

  • July 29, 2025

  • 7 min